Evercore ISI analyst Vijay Kumar reiterated an Outperform rating and $103.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Medtronic, Inc. (MDT) PT Lowered to $103 at Evercore ISIMay 21, 2025 4:00 PM Medtronic, Inc. (MDT) PT Lowered to $98 at CitiMay 21, 2025 2:08 PM Medtronic (MDT) to separate Diabetes businessMay 21, 2025 7:49 AM JPMorgan Reiterates Neutral Rating on Medtronic, Inc. (MDT)May 21, 2025 7:21 AM Medtronic (MDT) Raises Quarterly Dividend 1.4% to $0.71; 3.3% Yield, 48th consecutive year of an increase in the dividend paymentMay 21, 2025 7:00 AM Form 8-K Medtronic plc For: May 21May 21, 2025 6:47 AM Medtronic (MDT) Tops Q4 EPS by 4c; guides belowMay 21, 2025 6:47 AM Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increaseMay 21, 2025 6:45 AM Medtronic announces intent to separate Diabetes businessMay 21, 2025 6:44 AM Medtronic to separate diabetes business following recent strugglesMay 21, 2025 5:18 AM Medtronic (MDT) to Separate Diabetes Business - WSJMay 21, 2025 5:10 AM Medtronic (MDT) to Separate Diabetes Business as Stand-Alone Company -- WSJMay 21, 2025 5:07 AM Medtronic (MDT) May 23 weekly option implied volatility elevated into quarter results May 20, 2025 9:55 AM Medtronic (MDT) call put ratio 1 call to 3.1 puts into quarter resultsMay 20, 2025 6:03 AM Needham Reiterates Hold Rating on Medtronic, Inc. (MDT) ahead of earningsMay 19, 2025 7:05 AM